Literature DB >> 8326389

Distribution of deoxyglucose and technetium-99m-glucarate in the acutely ischemic myocardium.

H Yaoita1, A J Fischman, R Wilkinson, B A Khaw, M Juweid, H W Strauss.   

Abstract

The regional myocardial distribution of 99mTc-glucarate was compared to 3H-deoxyglucose in 22 rabbits with left circumflex marginal artery occlusion. In 12 rabbits, tissue radioactivity measurements were compared to the results of triphenyl tetrazolium chloride staining and light microscopy. In 10 additional rabbits, the myocardial sodium space (24NaCl), an indicator of tissue edema induced by injury, was compared to the distribution of deoxyglucose and glucarate. Technetium-99m-glucarate accumulated in injured myocardium within 6 hr after coronary ligation and myocardial concentration was greatest in the most severely injured zones (TTC unstained). Hydrogen-3-deoxyglucose behaved as a marker of ischemia but concentrated in tissue with injury ranging from mild ischemia (TTC stained) to transmural infarction (TTC unstained). Both 99mTc-glucarate and 3H-deoxyglucose concentrated in acute, severely injured myocardial tissue. These studies suggest that 99mTc-glucarate is a useful tracer for evaluating myocardial injury. In addition, it appears that 99mTc-glucarate and 3H-deoxyglucose demarcate different points in the spectrum of myocardial injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8326389

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  10 in total

1.  Avidity of technetium 99m glucarate for the necrotic myocardium: in vivo and in vitro assessment.

Authors:  B A Khaw; A Nakazawa; S M O'Donnell; K Y Pak; J Narula
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

2.  Differentiation of myocardial ischemia and necrosis by technetium 99m glucaric acid kinetics.

Authors:  R S Beanlands; T D Ruddy; L Bielawski; H Johansen
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

3.  99mTc-glucarate kinetics differentiate normal, stunned, hibernating, and nonviable myocardium in a perfused rat heart model.

Authors:  David R Okada; Zhonglin Liu; Gerald Johnson; Delia Beju; Ban An Khaw; Robert D Okada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-24       Impact factor: 9.236

4.  Technetium 99m glucarate: what will be its clinical role?

Authors:  M C Gerson; A J McGoron
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

5.  Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia.

Authors:  D R Okada; G Johnson; Z Liu; S D Hocherman; B A Khaw; K Y Pak; R D Okada
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

Review 6.  Transfer from PET to SPET in cardiology, but the unit of reference is still the patient.

Authors:  O Schober; E Moser
Journal:  Eur J Nucl Med       Date:  1994-06

7.  Technetium-99m glucarate uptake in a swine model of limited flow plus increased demand.

Authors:  L L Johnson; L Schofield; P Mastrofrancesco; T Donahay; A Farb; B A Khaw
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

8.  (99m)Tc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium.

Authors:  Gerald Johnson; Christine C Okada; Sonia D Hocherman; Zhonglin Liu; Curtis Hart; Ban-An Khaw; Robert D Okada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-20       Impact factor: 9.236

9.  Could 99mTc-glucarate be used to evaluate tumour necrosis? In vitro and in vivo studies in leukaemic tumour cell line U937.

Authors:  Nathalie Perek; Odile Sabido; Nathalie Le Jeune; Nathalie Prevot; Jean-Michel Vergnon; Anthony Clotagatide; Francis Dubois
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03-13       Impact factor: 9.236

Review 10.  Non-invasive in vivo imaging of myocardial apoptosis and necrosis.

Authors:  Albert Flotats; Ignasi Carrió
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-14       Impact factor: 9.236

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.